Sex differences in hepatitis A virus infection in mice
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1014660 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Ichiro Misumi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Hauptthemen laut MEDLINE: Hepatitis A, Hepatitis A virus, Sex Characteristics. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Epidemiological studies show that more men are hospitalized for severe hepatitis A than women. However, the extent to which social and behavioral differences versus intrinsic biological mechanisms account for this disparity in disease incidence remains unclear. To better define how sex influences infection outcome, we challenged male and female Ifnar1 -/- mice with HAV and quantified virus replication and liver injury. Male mice replicated and shed more virus than female mice, and demonstrated both accelerated and more severe liver injury, as evidenced by increased serum alanine aminotransferase (ALT) activity, greater immune cell infiltration in the liver, and higher intrahepatic expression of chemokines and interferon-stimulated genes. Sex differences were apparent in young and older adult mice, indicating that age did not significantly influence these effects. Ovariectomized female mice had higher intrahepatic viral loads, greater serum ALT elevation, and more severe pathology, compared to surgical controls. Conversely, ovariectomized mice given estradiol implants showed reduced viral loads and ALT activity, indicating that estrogen exerts a protective effect. Female Ifnar1 -/- mice lacking hepatocellular expression of estrogen receptor were phenotypically similar to those expressing Esr1 , indicating that direct ESR1 signaling in hepatocytes is not essential for protection against pathogenesis. Collectively, these findings indicate that sex influences the pathogenesis and outcome of HAV infection and that female sex hormones protect against severe liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America.
- Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
ORCID-Profile: Jason K Whitmire
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
- U.S. Department of Defense
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Misumi, I., Shiota, I., Shiota, T., Zhao, J., Cullen, J. M., Lemon, S. M., & Whitmire, J. K. (2026). Sex differences in hepatitis A virus infection in mice. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014660
Vancouver
Misumi I, Shiota I, Shiota T, Zhao J, Cullen JM, Lemon SM, et al. Sex differences in hepatitis A virus infection in mice. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014660
BibTeX
@article{Misumi2026,
author = {Misumi, Ichiro and Shiota, Itoe and Shiota, Tomoyuki and Zhao, Jingyu and Cullen, John M and Lemon, Stanley M and Whitmire, Jason K},
title = {Sex differences in hepatitis A virus infection in mice},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1014660}
}
EUVIMED